Trial Profile
Treatment of Incontinence Without Memory Problems (TRIUMPH)
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 17 Apr 2019
Price :
$35
*
At a glance
- Drugs Mirabegron (Primary) ; Tolterodine
- Indications Urinary incontinence
- Focus Therapeutic Use
- Acronyms TRIUMPH
- 29 Nov 2018 Status changed from active, no longer recruiting to completed.
- 15 Sep 2017 Status changed from recruiting to active, no longer recruiting.
- 24 Oct 2016 Planned End Date changed from 1 Jul 2017 to 1 Jul 2018.